查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1492342

血流感染检测市场：按产品类型、技术和最终用途划分 - 2024-2030 年全球预测

Bloodstream Infection Testing Market by Product (Instruments, Reagents & Consumables), Sample Type (Blood Culture, Whole Blood), Technology, End-use - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年血流感染检测市场规模为11.2亿美元，预计2024年将达12亿美元，2030年将达18.8亿美元，复合年增长率为7.64%。

血流感染检测市场包括各种诊断和分析技术，用于识别血液中导致全身感染的病原体和污染物。血流感染疾病在全球范围内迅速增加，增加了对有效检测解决方案的需求。诊断技术的进步正在提高血液检测的速度和准确性。全球医疗保健支出的增加将推动先进诊断解决方案的采用。然而，严格的监管要求漫长而复杂，减缓了新测试进入市场的速度。特别是在新兴市场，经常缺乏能够执行和解释高阶诊断测试的技术人员，从而造成市场进入挑战。此外，人工智慧和机器学习可用于完善诊断过程，使其更快、更准确。无需大型实验室即可现场快速测试的可携式设备的开拓可能为市场带来巨大的成长机会。

主要市场统计
基准年[2023] 11.2亿美元
预测年份 [2024] 12亿美元
预测年份 [2030] 18.8亿美元
复合年增长率（%） 7.64%

区域洞察

由于先进的医疗基础设施和 FDA 对诊断方法的严格规定，血流感染检测在美洲地区受到高度重视。在美国和加拿大，消费者对先进诊断的可用性的认识很高，这推动了对尖端测试解决方案的需求。在欧洲国家，由于发达的公共医疗保健系统和高标准的患者照护，血流感染检测技术的采用普遍增加。由于医疗保健支出增加以及医院设施现代化的努力（包括采用自动化微生物检测系统以提高诊断效率和准确性），中东是一个不断增长的市场。儘管非洲是多样化的，一些地区由于医疗基础设施有限而面临挑战，但国际援助机构和各国政府正在积极努力提高其检测感染疾病的能力，其中也包括失控感染的检测。在亚太地区，由于政府旨在提高医疗保健整体品质的医疗改革，中国血流感染检测市场正在迅速扩大。凭藉政府对医疗保健技术研究的大力支持，日本企业往往处于推出创新诊断产品的最前线。由于医疗基础设施的改善和政府加大医疗改革倡议，特别是注重减轻感染疾病的整体负担，印度的血液感染检测正在强劲增长。

FPNV定位矩阵

FPNV 定位矩阵对于评估供应商在血流感染测试市场的定位至关重要。此矩阵提供了对供应商的全面评估，并检验了与商务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果，供应商被分为代表其成功程度的四个像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对血流感染检测市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献，您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外，该分析还提供了对该行业竞争力的宝贵见解，包括研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息，供应商可以做出更明智的决策并製定有效的策略，以在市场竞争中保持领先地位。

策略分析与建议

策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在血流感染检测市场中的地位进行全面评估，使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析，以确定核心优势和需要改进的领域。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界各地的血流感染疾病呈上升趋势
      • 使用基于血液的诊断策略的趋势
      • 政府旨在提高人们对血液相关疾病的认识并改善血液安全的倡议
    • 抑制因素
      • 报销政策复杂且保险范围不足
    • 机会
      • 旨在开发新的血液检测、基于血液的抗菌检测和次世代定序的研究活动
      • 采用人工智慧、机器学习技术和新生物标记进行血流感染检测
    • 任务
      • 血流感染检测的技术和临床局限性以及污染的可能性
  • 市场区隔分析
    • 产品：探索血流感染检测设备以获得快速可靠的检测结果
    • 最终用途：诊断中心的多功能用途，以实现高效测试
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章血流感染检测市场：副产品

  • 装置
  • 试剂/耗材

第七章依样本类型分類的血流感染检测市场

  • 血液培养
  • 全血

第八章血流感染检测市场：依技术分类

  • 原位杂交
  • 质谱
  • PCR

第九章血流感染检测市场：依最终用途分类

  • 学术研究所
  • 诊断中心
  • 医院

第十章 北美和南美血流感染检测市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太血流感染检测市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的血流感染检测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争场景分析
    • 将血液检测和人工智慧结合，实现败血症管理中的高阶诊断、早期检测和风险评估
    • 战略伙伴关係加强了波兰对血流感染疾病和败血症的诊断
    • Oxford Nanopore 与 Day Zero Diagnostics 之间的创新合作，用于快速血流感染疾病诊断
  • 战略分析和建议

第14章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-4D00F1312BD4

[181 Pages Report] The Bloodstream Infection Testing Market size was estimated at USD 1.12 billion in 2023 and expected to reach USD 1.20 billion in 2024, at a CAGR 7.64% to reach USD 1.88 billion by 2030.

The bloodstream infection testing market includes a range of diagnostic and analytical techniques used to identify pathogens or contaminants in the blood that lead to systemic infections. The surge in cases of bloodstream infections globally fuels the need for effective testing solutions. Technological advancements in diagnostic technologies enhance the speed and accuracy of blood tests. Increased healthcare expenditure worldwide fuels the adoption of advanced diagnostic solutions. However, stringent regulatory requirements can be lengthy and complex, delaying market entry for new tests. Especially in emerging markets, there is often a shortage of skilled personnel to perform and interpret advanced diagnostic tests, creating challenges in the market space. Moreover, leveraging artificial intelligence and machine learning can refine diagnostic processes, making them faster and more accurate. The development of portable devices for rapid at-site testing without the need for extensive lab facilities may create significant growth opportunities in the market.

KEY MARKET STATISTICS
Base Year [2023] USD 1.12 billion
Estimated Year [2024] USD 1.20 billion
Forecast Year [2030] USD 1.88 billion
CAGR (%) 7.64%

Regional Insights

In the Americas region, bloodstream infection testing is highly prioritized due to the advanced healthcare infrastructure and stringent regulations by the FDA regarding diagnostic procedures. There is a high level of consumer awareness in the United States and Canada regarding the availability of advanced diagnostics, which drives demand for cutting-edge testing solutions. European countries typically show a strong adoption of bloodstream infection testing technologies due to their well-funded public health systems and high patient care standards. The Middle East presents a growing market, with increasing healthcare expenditure and initiatives to modernize hospital facilities, including adopting automated systems for microbial testing to enhance the efficiency and accuracy of diagnostics. Africa is diverse; while some regions face challenges due to limited healthcare infrastructure, there is a significant effort by international aid organizations and governments to improve infectious disease detection capabilities, which includes bloodstream infection testing. In the Asia Pacific region, China's market for bloodstream infection testing is expanding rapidly, driven by government health reforms aimed at improving the overall quality of healthcare. Due to strong governmental support for healthcare technology research, Japanese companies are often at the forefront of launching innovative diagnostic products. India is seeing significant growth in bloodstream infection testing, driven by both rising healthcare infrastructure and increased government initiatives towards healthcare reform, particularly focused on decreasing the overall burden of infectious diseases

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Bloodstream Infection Testing Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Rising number of bloodstream infections across the world
      • Inclination towards utilization of blood-based diagnostics strategies
      • Government initiatives to raise awareness about blood-related diseases and improve blood safety
    • Market Restraints
      • Complex reimbursement policies and inadequate insurance coverage
    • Market Opportunities
      • Research activities to develop novel blood tests, blood-based antimicrobial tests, and next-generation sequencing
      • Adoption of AI, ML technologies, and new biomarkers for bloodstream infection testing
    • Market Challenges
      • Technical and clinical limitations of bloodstream infection testing and chances of contamination
  • Market Segmentation Analysis
    • Product: Exploring bloodstream infection testing instruments for rapid and reliable test results
    • End-use: Diverse scope of applications in diagnostic centers for efficient testing
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Bloodstream Infection Testing Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Bloodstream Infection Testing Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Advanced Diagnostics in Sepsis Management, Integrating Blood Testing and AI for Early Detection and Risk Assessment

In a significant breakthrough in medical diagnostics, researchers have developed a dual approach combining a blood test and artificial intelligence to enhance the early detection of sepsis, potentially saving countless lives. Sepsis, a critical condition marked by the body's overwhelming and life-threatening response to infection. Despite the need for further clinical validation before widespread implementation, this approach represents a promising advancement in the fight against sepsis, aligning with the goals of enhancing diagnostic precision and improving patient prognoses. [Published On: 2024-03-29]

Strategic Partnership Enhances Bloodstream Infection and Sepsis Diagnostics in Poland

Becton, Dickinson and Company (BD) has formed a strategic alliance with The Great Orchestra of Christmas Charity (GOCC), to bolster the country's capabilities in diagnosing bloodstream infections (BSIs) and managing sepsis. This partnership is set to equip over 150 Polish healthcare facilities with sophisticated diagnostic systems such as the BD Bruker MALDI Biotyper sirius IVD System and the BD Phoenix M50 Systems. This initiatives are aligned with BD's commitment to improve health access and equity within the region, facilitating faster and more accurate medical responses essential for tackling the global health challenges. [Published On: 2024-03-15]

Innovative Collaboration for Rapid Bloodstream Infection Diagnostics, Oxford Nanopore and Day Zero Diagnostics Join Forces

Oxford Nanopore Technologies and Day Zero Diagnostics have entered into a strategic collaboration to revolutionize the diagnosis of bloodstream infections, an essential step in mitigating sepsis risks. This initiative aims to establish a comprehensive diagnostic system capable of offering same-day identification and genomic-based assessments of antibiotic resistance, directly from patient samples without the reliance on traditional blood cultures. [Published On: 2023-11-17]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Bloodstream Infection Testing Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Bloodstream Infection Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accelerate Diagnostics, Inc., Advacare Pharma, Bactiguard AB, Becton, Dickinson and Company, BioMerieux, Bruker Corporation, Cardinal Health, Cepheid, CorMedix Inc., Diasorin S.p.A., F. Hoffmann-La Roche Ltd, Fresenius Medical Care AG & Co. KGaA, HiMedia Laboratories Pvt. Ltd, ITL Health Group, Johnson & Johnson Services, Inc, Kurin Inc., Merck & Co., Inc., Novartis AG, Novo Holdings A/S, Pfizer Inc., Pro-Lab Diagnostics, Sanofi S.A., Sepsis Alliance, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Bloodstream Infection Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Instruments
    • Reagents & Consumables
  • Sample Type
    • Blood Culture
    • Whole Blood
  • Technology
    • In Situ Hybridization
    • Mass Spectroscopy
    • PCR
  • End-use
    • Academic & Research Institutes
    • Diagnostic Centers
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising number of bloodstream infections across the world
      • 5.1.1.2. Inclination towards utilization of blood-based diagnostics strategies
      • 5.1.1.3. Government initiatives to raise awareness about blood-related diseases and improve blood safety
    • 5.1.2. Restraints
      • 5.1.2.1. Complex reimbursement policies and inadequate insurance coverage
    • 5.1.3. Opportunities
      • 5.1.3.1. Research activities to develop novel blood tests, blood-based antimicrobial tests, and next-generation sequencing
      • 5.1.3.2. Adoption of AI, ML technologies, and new biomarkers for bloodstream infection testing
    • 5.1.4. Challenges
      • 5.1.4.1. Technical and clinical limitations of bloodstream infection testing and chances of contamination
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Exploring bloodstream infection testing instruments for rapid and reliable test results
    • 5.2.2. End-use: Diverse scope of applications in diagnostic centers for efficient testing
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Bloodstream Infection Testing Market, by Product

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Reagents & Consumables

7. Bloodstream Infection Testing Market, by Sample Type

  • 7.1. Introduction
  • 7.2. Blood Culture
  • 7.3. Whole Blood

8. Bloodstream Infection Testing Market, by Technology

  • 8.1. Introduction
  • 8.2. In Situ Hybridization
  • 8.3. Mass Spectroscopy
  • 8.4. PCR

9. Bloodstream Infection Testing Market, by End-use

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Diagnostic Centers
  • 9.4. Hospitals

10. Americas Bloodstream Infection Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Bloodstream Infection Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Bloodstream Infection Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Advanced Diagnostics in Sepsis Management, Integrating Blood Testing and AI for Early Detection and Risk Assessment
    • 13.3.2. Strategic Partnership Enhances Bloodstream Infection and Sepsis Diagnostics in Poland
    • 13.3.3. Innovative Collaboration for Rapid Bloodstream Infection Diagnostics, Oxford Nanopore and Day Zero Diagnostics Join Forces
  • 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. BLOODSTREAM INFECTION TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. BLOODSTREAM INFECTION TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. BLOODSTREAM INFECTION TESTING MARKET DYNAMICS
  • FIGURE 7. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. BLOODSTREAM INFECTION TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. BLOODSTREAM INFECTION TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BLOODSTREAM INFECTION TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BLOOD CULTURE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY BLOOD CULTURE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY IN SITU HYBRIDIZATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY IN SITU HYBRIDIZATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MASS SPECTROSCOPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY MASS SPECTROSCOPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PCR, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PCR, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 36. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 37. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 38. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 39. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 40. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 43. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 44. AMERICAS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 45. ARGENTINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 46. ARGENTINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 47. ARGENTINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 48. ARGENTINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 49. ARGENTINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 50. ARGENTINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 51. ARGENTINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 52. ARGENTINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 53. BRAZIL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 54. BRAZIL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 55. BRAZIL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 56. BRAZIL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 57. BRAZIL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 58. BRAZIL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 59. BRAZIL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 60. BRAZIL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 61. CANADA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 62. CANADA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 63. CANADA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 64. CANADA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 65. CANADA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 66. CANADA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 67. CANADA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 68. CANADA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 69. MEXICO BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 70. MEXICO BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 71. MEXICO BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 72. MEXICO BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 73. MEXICO BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 74. MEXICO BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 75. MEXICO BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 76. MEXICO BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 77. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 78. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 79. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 80. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 81. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 82. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 83. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 84. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 85. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 86. UNITED STATES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 98. AUSTRALIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 100. AUSTRALIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 102. AUSTRALIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 104. AUSTRALIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 105. CHINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 106. CHINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 107. CHINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 108. CHINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 109. CHINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 110. CHINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 111. CHINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 112. CHINA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 113. INDIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 114. INDIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 115. INDIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. INDIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. INDIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 118. INDIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 119. INDIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 120. INDIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 121. INDONESIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 122. INDONESIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 123. INDONESIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 124. INDONESIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 125. INDONESIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 126. INDONESIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 127. INDONESIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 128. INDONESIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 129. JAPAN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 130. JAPAN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 131. JAPAN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 132. JAPAN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 133. JAPAN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 134. JAPAN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 135. JAPAN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 136. JAPAN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 137. MALAYSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 138. MALAYSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 139. MALAYSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 140. MALAYSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 141. MALAYSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 142. MALAYSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 143. MALAYSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 144. MALAYSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 145. PHILIPPINES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 146. PHILIPPINES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 147. PHILIPPINES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 148. PHILIPPINES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 149. PHILIPPINES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 150. PHILIPPINES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 151. PHILIPPINES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 152. PHILIPPINES BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 153. SINGAPORE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 154. SINGAPORE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 155. SINGAPORE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 156. SINGAPORE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 157. SINGAPORE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 158. SINGAPORE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 159. SINGAPORE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 160. SINGAPORE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 161. SOUTH KOREA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 162. SOUTH KOREA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 163. SOUTH KOREA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 164. SOUTH KOREA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 165. SOUTH KOREA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 166. SOUTH KOREA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 167. SOUTH KOREA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 168. SOUTH KOREA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 169. TAIWAN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 170. TAIWAN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 171. TAIWAN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. TAIWAN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. TAIWAN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 174. TAIWAN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 175. TAIWAN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 176. TAIWAN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 177. THAILAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 178. THAILAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 179. THAILAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 180. THAILAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 181. THAILAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 182. THAILAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 183. THAILAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 184. THAILAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 185. VIETNAM BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 186. VIETNAM BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 187. VIETNAM BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 188. VIETNAM BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 189. VIETNAM BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 190. VIETNAM BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 191. VIETNAM BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 192. VIETNAM BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 203. DENMARK BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 204. DENMARK BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 205. DENMARK BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 206. DENMARK BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 207. DENMARK BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 208. DENMARK BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 209. DENMARK BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 210. DENMARK BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 211. EGYPT BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 212. EGYPT BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 213. EGYPT BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 214. EGYPT BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 215. EGYPT BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 216. EGYPT BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 217. EGYPT BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 218. EGYPT BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 219. FINLAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 220. FINLAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 221. FINLAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 222. FINLAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 223. FINLAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 224. FINLAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 225. FINLAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 226. FINLAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 227. FRANCE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 228. FRANCE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 229. FRANCE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 230. FRANCE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 231. FRANCE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 232. FRANCE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 233. FRANCE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 234. FRANCE BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 235. GERMANY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 236. GERMANY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 237. GERMANY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 238. GERMANY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 239. GERMANY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 240. GERMANY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 241. GERMANY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 242. GERMANY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 243. ISRAEL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 244. ISRAEL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 245. ISRAEL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 246. ISRAEL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 247. ISRAEL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 248. ISRAEL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 249. ISRAEL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 250. ISRAEL BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 251. ITALY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 252. ITALY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 253. ITALY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 254. ITALY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 255. ITALY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 256. ITALY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 257. ITALY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 258. ITALY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 259. NETHERLANDS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 260. NETHERLANDS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 261. NETHERLANDS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 262. NETHERLANDS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 263. NETHERLANDS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 264. NETHERLANDS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 265. NETHERLANDS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 266. NETHERLANDS BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 267. NIGERIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 268. NIGERIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 269. NIGERIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 270. NIGERIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 271. NIGERIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 272. NIGERIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 273. NIGERIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 274. NIGERIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 275. NORWAY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 276. NORWAY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 277. NORWAY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 278. NORWAY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 279. NORWAY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 280. NORWAY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 281. NORWAY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 282. NORWAY BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 283. POLAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 284. POLAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 285. POLAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 286. POLAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 287. POLAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 288. POLAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 289. POLAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 290. POLAND BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 291. QATAR BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 292. QATAR BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 293. QATAR BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 294. QATAR BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 295. QATAR BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 296. QATAR BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 297. QATAR BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 298. QATAR BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 299. RUSSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 300. RUSSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 301. RUSSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 302. RUSSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 303. RUSSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 304. RUSSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 305. RUSSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 306. RUSSIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 307. SAUDI ARABIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 308. SAUDI ARABIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 309. SAUDI ARABIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 310. SAUDI ARABIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 311. SAUDI ARABIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 312. SAUDI ARABIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 313. SAUDI ARABIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 314. SAUDI ARABIA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 315. SOUTH AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 316. SOUTH AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 317. SOUTH AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 318. SOUTH AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 319. SOUTH AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 320. SOUTH AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 321. SOUTH AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 322. SOUTH AFRICA BLOODSTREAM INFECTION TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 323. SPAIN BLOODSTREAM INFECTION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 324. SPAIN BLOODSTREAM INFECTION